Century Therapeutics, INC. 8-K Filing
Ticker: IPSC · Form: 8-K · Filed: Dec 29, 2025 · CIK: 1850119
Sentiment: neutral
Filing Stats: 463 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-12-29 16:05:35
Key Financial Figures
- $0.0001 — ch Registered Common Stock, par value $0.0001 per share IPSC Nasdaq Capital Marke
Filing Documents
- tm2533998d1_8k.htm (8-K) — 24KB
- 0001104659-25-124836.txt ( ) — 186KB
- ipsc-20251218.xsd (EX-101.SCH) — 3KB
- ipsc-20251218_lab.xml (EX-101.LAB) — 33KB
- ipsc-20251218_pre.xml (EX-101.PRE) — 22KB
- tm2533998d1_8k_htm.xml (XML) — 3KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 18, 2025, Carlo Rizzuto, Ph.D. notified the board of directors (the "Board") of Century Therapeutics, Inc. (the "Company") of his intent to resign from the Board, effective December 18, 2025. Dr. Rizzuto's decision to resign was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. The Company extends its deepest gratitude to Dr. Rizzuto for his distinguished service to the Board and lasting contributions to the Company.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CENTURY THERAPEUTICS, INC. By: /s/ Brent Pfeiffenberger, PharmD, MBA Name: Brent Pfeiffenberger, PharmD, MBA Title: President and Chief Executive Officer Date: December 29, 2025